Skip to Content

News Releases

News Releases

Date Title and Summary
Toggle Summary Option Care Health Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year and Schedules Fourth Quarter Earnings Call
BANNOCKBURN, Ill. , Feb. 08, 2021 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“ Option Care Health” or the “Company”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, announced today preliminary financial results for the fourth
Toggle Summary Option Care Health Announces Issuance of $250 Million in Additional First Lien Term Loan and Concurrent Extinguishment of All Outstanding Second Lien Notes
BANNOCKBURN, Ill. , Jan. 21, 2021 (GLOBE NEWSWIRE) -- Option Care Health Inc. (NASDAQ: OPCH)(“Option Care Health” or the Company”), the nation’s largest independent home and alternate site infusion services provider, announced today that it has successfully issued $250 million in additional first
Toggle Summary Leading Healthcare Services Organizations Collaborate to Provide Innovative COVID Therapy Access Model
BATON ROUGE, La. , and BANNOCKBURN, Ill. , Jan. 05, 2021 (GLOBE NEWSWIRE) -- Amedisys , Inc. (NASDAQ: AMED), a leading provider of home health, hospice and personal care, and Option Care Health Inc. (NASDAQ: OPCH), the nation’s largest independent home and alternate site infusion services provider,
Toggle Summary Option Care Health to Participate in Upcoming Virtual Investor Conference
BANNOCKBURN, Ill. , Dec. 22, 2020 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“ Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will present at the 39 th Annual J.P.
Toggle Summary Option Care Health Announces Pricing of Secondary Offering of 10,000,000 Shares of Common Stock
BANNOCKBURN, Ill. , Dec. 10, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“ Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Madison Dearborn Partners (the “Selling Stockholder”) has agreed to sell 10,000,000 shares of the Company’s common stock at a
Toggle Summary Option Care Health Announces Secondary Offering of 10,000,000 Shares of Common Stock
BANNOCKBURN, Ill. , Dec. 10, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“ Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Madison Dearborn Partners (the “Selling Stockholder”) has agreed to sell 10,000,000 shares of the Company’s common stock in an
Toggle Summary Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2020
BANNOCKBURN, Ill. , Nov. 03, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “ Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30,
Toggle Summary Option Care Health to Announce Third Quarter 2020 Financial Results and Host Conference Call
BANNOCKBURN, Ill. , Oct. 13, 2020 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“ Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, today announced that the company will release results for its third quarter ended
Toggle Summary Option Care Health to Participate in Upcoming Virtual Investor Conference
BANNOCKBURN, Ill. , Sept. 03, 2020 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“ Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the Lake Street 4 th Annual Best Ideas Growth Conference ,
Toggle Summary Option Care Health Selected as a Limited Distribution Provider of VILTEPSO™ (viltolarsen) Injection for Patients with Duchenne Muscular Dystrophy in Patients Amenable to Exon 53 Skipping Therapy
BANNOCKBURN, Ill. , Sept. 02, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc.  (“ Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, has been selected to participate in the limited distribution network of VILTEPSO™